ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.077,54
-0,98%
S&P 500
5.705,45
-1,86%
Dow Jones
41.763,46
-0,90%
Euro vs US Dollar
1,08854
0,24%
Bitcoin
70.207,78
-2,94%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Oyster Point Pharma Inc (OYST)

  7. Oyster Point Pharma Inc (OYST) News

OYST

Oyster Point Pharma (OYST)

Oyster Point Pharma Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:OYST
DatumZeitQuelleÜberschriftSymbolFirma
14/02/202322h34Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:OYSTOyster Point Pharma Inc
14/02/202316h06Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:OYSTOyster Point Pharma Inc
13/01/202323h11Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:OYSTOyster Point Pharma Inc
13/01/202323h06Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:OYSTOyster Point Pharma Inc
06/01/202312h04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:OYSTOyster Point Pharma Inc
05/01/202322h33Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:OYSTOyster Point Pharma Inc
05/01/202322h32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OYSTOyster Point Pharma Inc
05/01/202300h12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OYSTOyster Point Pharma Inc
04/01/202323h11Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OYSTOyster Point Pharma Inc
04/01/202323h10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OYSTOyster Point Pharma Inc
04/01/202323h09Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OYSTOyster Point Pharma Inc
04/01/202323h05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OYSTOyster Point Pharma Inc
04/01/202323h03Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OYSTOyster Point Pharma Inc
04/01/202323h03Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OYSTOyster Point Pharma Inc
03/01/202315h53Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:OYSTOyster Point Pharma Inc
03/01/202315h26Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:OYSTOyster Point Pharma Inc
03/01/202315h19Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:OYSTOyster Point Pharma Inc
03/01/202315h07Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:OYSTOyster Point Pharma Inc
23/12/202212h31Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:OYSTOyster Point Pharma Inc
22/12/202223h16Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:OYSTOyster Point Pharma Inc
21/12/202212h04Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:OYSTOyster Point Pharma Inc
09/12/202213h01Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:OYSTOyster Point Pharma Inc
09/12/202213h01Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:OYSTOyster Point Pharma Inc
06/12/202214h51Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OYSTOyster Point Pharma Inc
05/12/202223h37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OYSTOyster Point Pharma Inc
02/12/202214h00GlobeNewswire Inc.Oyster Point Pharma, Inc., Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:OYSTOyster Point Pharma Inc
01/12/202213h39Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:OYSTOyster Point Pharma Inc
01/12/202212h12Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:OYSTOyster Point Pharma Inc
16/11/202222h25Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:OYSTOyster Point Pharma Inc
14/11/202214h10Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:OYSTOyster Point Pharma Inc
 Showing the most relevant articles for your search:NASDAQ:OYST

Kürzlich von Ihnen besucht

TG
BAS
BASF
NASDAQ
GOOGL
Alphabet
FX
EURUSD
Euro vs US Dollar
AMEX
XLE
Energy Select Sector SPDR
FX
EURJPY
Euro vs Yen
NASDAQ
AAPL
Apple
DBI
TDXP
Tec DAX
DBI
SDXP
SDAX
USOTC
DTEGY
Deutsche Telekom (QX)
COIN
DOGEUSD
Dogecoin
TG
ALV
Allianz
AMEX
XLV
Health Care Select Sector
DBI
DAX
DAX
NYSE
JPM
JP Morgan Chase
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten